4th Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$51,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
S. 369 - A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of generic drug in to the market, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President - WH Leg Affairs |
Budget/Appropriations BUD
H.R. 3082 Continuing Appropriations and Surface Transportation
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President - WH Leg Affiar |
Health Issues HCR
Health care implementation P.L. 111-148 - The Patient Protection and Affordable Care Act P.L. 111-152 - The Reconciliation Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President - WH Leg Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.